Company Information
Industry News
02/11 .2025
Biominhai Collaborates with Dek Vaccines for 13-Valent PCV Technology Transfer and Drug Supply
12/18 .2025
Biokangtai’s 60 μg Hepatitis B Vaccine Approved for Clinical Trial in Relapse Prevention
12/02 .2025
Delighted to Share a Proud Moment for Our Team
10/15 .2025
BioMinhai's Live Attenuated Varicella Vaccine Receives DRAP Approval for Launch in Pakistan
08/25 .2025
New to BioKangtai R&D Pipeline: Klebsiella pneumoniae Vaccine
BioKangtai Celebrates a Significant Milestone Achievement
05/27 .2025
Join Us at CPHI China 2025 （#W4G66）
